Jerusalem, Israel

Lital Magid

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Other. Active years: 2014-2016.


% Patents Active = 50.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lital Magid: Innovator in Medicinal Chemistry

Introduction

Lital Magid is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Lital Magid's latest patents include the invention of arylated camphenes, which are processes for their preparation and uses in the manufacture of medicaments. These inventions are particularly relevant for the treatment of diseases, disorders, or conditions that benefit from the stimulation of CB2 receptors. His research aims to enhance the efficacy of treatments through these novel compounds.

Career Highlights

Throughout his career, Lital has worked with esteemed organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding and application of medicinal chemistry.

Collaborations

Lital has collaborated with notable figures in the field, including Raphael Mechoulam and Esther Shohami. These partnerships have contributed to the depth and impact of his research.

Conclusion

Lital Magid's innovative work in medicinal chemistry showcases his commitment to advancing healthcare solutions. His contributions through patents and collaborations highlight the importance of research in developing effective treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…